The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles

Abstract

The objectivewas to study the occurrenceof autoantibodiesand cytokinesin serum and cerebrospinal fluid (CSF) in neuropsychiatric systemic lupus erythematosus (NPSLE). In total, 28 consecutive patients with NPSLE and 16 systemic lupus erythematosus (SLE) patients without neuropsychiatric involvement (non-NPSLE) were studied. IFN-a, IL-6, IL-10, soluble terminal complement complex (TCC), anti-ribosomal P protein antibodies (anti-P) and anti-cardiolipin antibodies (aCL) were measured in serum and CSF by immunoassays. Analyses of white blood cell differential count, CSF-albumin/serum-albumin ratio, IgG-index in CSF and isoelectric focusing in serum and CSF were also performed. CSF specimens from 23 healthy individuals were used as controls. IFN-a was elevated in the CSF of 5 of 28 NPSLE patients compared to three of 14 among the non-NPSLE patients. IL-6 was elevated in CSF in three of 26 NPSLE patients. Normal concentration of IL-10 was found in CSF in all 27 NPSLE-patients analysed. IFN-a in serum was elevated in 18 of 28 NPSLE patients. No distinct clinical phenotype was related to elevated cytokine concentration in serum or CSF. One patient with cerebral involvement complicated by progressive multifocal leukoencephalopathy displayed a very high IFN-a concentration in serum. High concentration of TCC was present in CSF from only one patient with systemic vasculitis and focal cerebral symptoms. In conclusion, the results of this study suggest that the diagnostic value of serum and CSF concentrationsof IFN-a, IL-10, IL-6 and TCC is limited in unselected neuropsychiatricSLE, probably due to the heterogeneityof NPSLE pathogenesis.

Keywords

cerebrospinal fluid cytokines interferon-alpha neuropsychiatric systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25(11): 1271-1277 .

Lindal E , Thorlacius S , Steinsson K , Stefansson JG. Psychiatric disorders among subjects with systemic lupus erythematosus in an unselected population . Scand J Rheumatol 1995; 24(6): 346-351 .

Winfield JB , Shaw M , Silverman LM , Eisenberg RA , Wilson HA III , Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction . Am J Med 1983; 74(5): 837-844 .

Schneebaum AB , Singleton JD , West SG et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus . Am J Med 1991; 90(1): 54-62 .

Shiozawa S , Kuroki Y , Kim M , Hirohata S , Ogino T. Interferon-alpha in lupus psychosis . Arthritis Rheum 1992; 35(4): 417-422 .

Hirohata S , Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement . Arthritis Rheum 1990; 33(5): 644-649 .

Trysberg E , Carlsten H , Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement . Lupus 2000; 9(7): 498-503 .

Sanders ME , Alexander EL , Koski CL , Frank MM , Joiner KA. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren’s syndrome or systemic lupus erythematosus . J Immunol 1987; 138(7): 2095-2099 .

Bombardier C , Gladman DD , Urowitz MB , Caron D , Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum 1992; 35(6): 630-640 .

10.

Gladman D , Ginzler E , Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus . Arthritis Rheum 1996; 39(3): 363-369 .

11.

How A , Dent PB , Liao SK , Denburg JA. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus . Arthritis Rheum 1985; 28(7): 789-795 .

12.

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes . Arthritis Rheum 1999; 42(4): 599-608 .

13.

Cederblad B , Blomberg S , Vallin H , Perers A , Alm GV , Ronnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells . J Autoimmun 1998; 11(5): 465-470 .

14.

Sturfelt G , Eskilsson J , Nived O , Truedsson L , Valind S. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population . Medicine (Baltimore) 1992; 71(4): 216-223 .

15.

Ronnblom L , Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus . J Exp Med 2001; 194(12): F59-F63 .

16.

Tsai CY , Wu TH , Tsai ST et al. Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections . Scand J Rheumatol 1994; 23(2): 57-63 .

17.

Bengtsson AA , Sturfelt G , Truedsson L et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies . Lupus 2000; 9(9): 664-671 .

18.

Laurenzi MA , Siden A , Persson MA , Norkrans G , Hagberg L , Chiodi F. Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system . Clin Immunol Immunopathol 1990; 57(2): 233-241 .

19.

van Dam A , Nossent H , de Jong J et al. Diagnostic value of antibodies against ribosomal phosphoproteins. A cross sectional and longitudinal study . J Rheumatol 1991; 18(7): 1026-1034 .

20.

Rayno K , Reichlin M. Evaluation of assays for the detection of autoantibodies to the ribosomal P proteins . Clin Immunol 2000; 95(2): 99-103 .